A carregar...
Considerations for immunotherapy in patients with cancer and comorbid immune dysfunction
Immune checkpoint inhibitors have been widely incorporated for cancer treatment in a variety of solid and hematologic malignancies. Multiple clinical trials have demonstrated the efficacy of PD-1/PD-L1 and CTLA-4 axis inhibition in the metastatic and adjuvant settings. Due to the risks of autoimmune...
Na minha lista:
| Publicado no: | Ann Transl Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8267318/ https://ncbi.nlm.nih.gov/pubmed/34277835 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-5207 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|